FdaApplication
ANDA 079075
Identifiers
- fda_app_no: ANDA079075
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2011-01-07 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.1MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.2MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.8MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.6MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.4MG BASE | TABLET;BUCCAL, SUBLINGUAL |
5 products